When a buyer values a company off a multiple of EBITDA, the number they apply that multiple to matters enormously. Reported EBITDA — the figure straight off the income statement — is rarely the number a sophisticated buyer actually pays for. Instead, buyers work from Normalized EBITDA (also called Adjusted EBITDA): reported EBITDA with non-recurring items stripped out.
Why Reported EBITDA Isn't the Right Starting Point
Reported EBITDA can be distorted in either direction by items that have nothing to do with the ongoing operating business: a one-time legal settlement, a restructuring charge, a gain on the sale of a non-core asset, or unusual advisory fees tied to an M&A process. None of these reflect what the business will earn next year under normal conditions. If you value the company on unadjusted EBITDA, you either pay too little (if one-time costs depressed the number) or too much (if one-time gains inflated it).
The Two Directions of Adjustment
Normalization runs in two directions:
Add-backs — one-time expenses that reduced reported EBITDA but won't recur (legal settlements, severance and restructuring costs, one-off advisory fees) get added back, since they understate the company's sustainable earnings power.
Deductions — one-time gains that inflated reported EBITDA (a gain on selling a non-core asset, a favorable litigation settlement) get removed, since they overstate what the business will earn going forward.
A common mistake is only doing the first half — analysts eager to make a company look better tend to add back every cost that looks unusual while conveniently forgetting to strip out one-time gains too.
The Judgment Call: What Counts as "Non-Recurring"?
The hard part isn't the arithmetic — it's the classification. A "one-time" restructuring charge that shows up every single year isn't really one-time; a disciplined buyer will either exclude that add-back entirely or discount it to reflect how often it actually recurs. Stock-based compensation is a frequent point of dispute: it's non-cash, but it's also a genuine, ongoing cost of retaining employees, so most sophisticated buyers exclude it from quality-of-earnings add-backs rather than normalizing it away.
Why This Matters So Much in a Sale Process
Because Enterprise Value = EBITDA multiple × EBITDA, every dollar of EBITDA a seller successfully normalizes upward directly increases the purchase price at a given multiple. That's exactly why buyers scrutinize every proposed add-back in a quality-of-earnings review, and why this is one of the most commonly tested concepts in sell-side M&A and private equity interviews — see our full walkthrough in EBITDA Normalization: A Worked Case, which builds a Normalized EBITDA bridge step by step from a set of reported figures and one-time items.
How This Connects to the EBITDA Bridge
Normalization is closely related to, but distinct from, the standard EBITDA bridge from Net Income, which adds back taxes, interest, and D&A to get from Net Income to EBITDA in the first place. Normalization is the next layer on top: once you have EBITDA, you still need to ask whether that number reflects a clean, sustainable run rate — or whether it's inflated or deflated by items that won't happen again.